Pharmaceutical agent comprising solifenacin

摘要: There is provided an agent comprising solifenacin succinate in amount of 5 mg to 10 or a pharmaceutically acceptable salt thereof equimolar for improvement urinary urgency, pollakiuria and incontinence due neurogenic bladder caused by neurodegenerative diseases such as cerebrovascular disease cerebral infarction, brain spinal cord injury trauma, multiple sclerosis, Parkinson's disease, congenital malformation the nerve system, peripheral neuropathy, various spine lesions, that is, compression fracture, cervical lumbar spondylosis, spondylosis deformans, spondylolisthesis, stenosis, vertebral disk hernia like.